-- Elizabeth E Reed, Chief Legal Officer and General Counsel, on April 13, 2026, sold 51,500 shares in Travere Therapeutics (TVTX) for $2,126,452. Following the Form 4 filing with the SEC, Reed has control over a total of 105,211 common shares of the company, with 105,211 shares held directly.
SEC Filing: